SCHOTT Pharma AG & Co. KGaA Stock
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.74 EUR | +1.85% | +6.94% | +18.27% |
Apr. 22 | SCHOTT PHARMA : Jefferies remains Neutral | ZD |
Apr. 11 | Gerresheimer very weak - Certain uncertainties about outlook | DP |
Sales 2024 * | 981M 1.05B | Sales 2025 * | 1.15B 1.23B | Capitalization | 5.99B 6.4B |
---|---|---|---|---|---|
Net income 2024 * | 151M 161M | Net income 2025 * | 189M 202M | EV / Sales 2024 * | 6.31 x |
Net Debt 2024 * | 201M 215M | Net Debt 2025 * | 184M 197M | EV / Sales 2025 * | 5.37 x |
P/E ratio 2024 * |
39.7
x | P/E ratio 2025 * |
31.8
x | Employees | 4,687 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.51% | Free-Float | 23% |
1 day | +1.85% | ||
1 week | +6.94% | ||
Current month | +0.35% | ||
1 month | -2.60% | ||
3 months | +17.57% | ||
6 months | +42.44% | ||
Current year | +18.27% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 22-06-30 |
Director of Finance/CFO | 43 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 22-12-31 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 22-12-31 |
Chairman | 59 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 39.74 | +1.85% | 36,632 |
24-04-25 | 39.02 | -0.20% | 46,582 |
24-04-24 | 39.1 | +0.15% | 36,636 |
24-04-23 | 39.04 | +1.83% | 27,170 |
24-04-22 | 38.34 | +3.18% | 65,731 |
Delayed Quote Xetra, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.27% | 6.39B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 1SXP Stock